Cerebrolysin vs Dihexa
Comprehensive side-by-side comparison of mechanisms, dosing, side effects, and research
Also: FPE 1070
A mixture of low-molecular-weight neuropeptides derived from pig brain. Approved in many countries for stroke, traumatic brain injury, and dementia.
Also: N-hexanoic-Tyr-Ile-(6) aminohexanoic amide
A potent cognitive-enhancing peptide derived from angiotensin IV. Reported to be 10 million times more potent than BDNF at promoting synaptogenesis.
Key Comparison Insights
- Both peptides belong to the Cognitive category, suggesting similar primary applications.
- Cerebrolysin has stronger research evidence (Human Trials) compared to Dihexa (Animal Studies).
Detailed Comparison
| Attribute | Cerebrolysin | Dihexa |
|---|---|---|
| Category | Cognitive | Cognitive |
| FDA Status | Not FDA Approved | Not FDA Approved |
| Clinical Status | Pre I II III IV FDA | Pre I II III IV FDA |
| Mechanism of Action | Cerebrolysin contains neurotrophic factors that mimic BDNF, NGF, and CNTF activity. It enhances neuroplasticity, protects neurons from excitotoxicity, promotes neurogenesis, and improves synaptic function. | Dihexa activates hepatocyte growth factor (HGF) signaling through the c-Met receptor. This promotes dendritic spine formation, enhances synaptic connections, and supports neuronal survival. Crosses blood-brain barrier orally. |
| Common Dosing | 5-10 ml IV/IM daily for 10-20 days Daily during treatment cycles | 5-20 mg oral or sublingual daily Once daily, effects can last up to 10 days |
| Administration | Intravenous or intramuscular injection | Oral, sublingual, or intranasal |
| Typical Duration | 10-20 day cycles | Cycles of 2-4 weeks |
| Best Time to Take | Morning | Morning |
Possible Side Effects May vary by individual |
|
|
| Research Summary | Approved in over 40 countries for neurological conditions. Studies show benefits in stroke recovery, Alzheimer's disease, and TBI. Large clinical trials demonstrate improved cognitive function and activities of daily living. | Animal studies show remarkable cognitive enhancement and reversal of scopolamine-induced memory deficits. Research demonstrates increased dendritic spine density. Limited human data but significant interest in nootropic community. |
Frequently Asked Questions: Cerebrolysin vs Dihexa
What is the difference between Cerebrolysin and Dihexa?
Cerebrolysin is a cognitive peptide that a mixture of low-molecular-weight neuropeptides derived from pig brain. approved in many countries for stroke, traumatic brain injury, and dementia. Dihexa is a cognitive peptide that a potent cognitive-enhancing peptide derived from angiotensin iv. reported to be 10 million times more potent than bdnf at promoting synaptogenesis. The main differences lie in their mechanisms of action and clinical applications.
Which is better, Cerebrolysin or Dihexa?
Neither is universally "better" - the choice depends on your specific goals. Cerebrolysin is typically used for cognitive purposes, while Dihexa is used for cognitive. Always consult with a healthcare provider to determine which may be appropriate for your situation.
Can Cerebrolysin and Dihexa be used together?
Some peptide protocols combine multiple compounds for synergistic effects. However, using Cerebrolysin and Dihexa together should only be considered under medical supervision, as both compounds have their own side effect profiles and potential interactions. Research on their combined use may be limited.
Related Comparisons
View Full Peptide Profiles
Educational Information Only
This comparison of Cerebrolysin and Dihexa is for educational purposes only. Neither this comparison nor any information on this site constitutes medical advice. Always consult with qualified healthcare providers before making decisions about peptides or other substances.